Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) (Q71303516)
Jump to navigation
Jump to search
scientific article published on 01 March 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) |
scientific article published on 01 March 1996 |
Statements
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) (English)
C Florent
A Cortot
P Quandale
T Sahmound
R Modigliani
E Sarfaty
P Valleur
J L Dupas
M Daurat
J L Faucheron
E Lerebours
F Michot
J Belaiche
N Jacquet
J C Soulé
N Rothman
J P Gendre
1 March 1996